Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Tuesday, November 29, 2005
Merck trial - Dodgeball document
With the third Merck Vioxx trial due to start today Insider thought that you might want to see this for yourself: Dodgeball
2 comments:
Anonymous
said...
Funny part is... Celepfizer is no safer. Pfizer just did a better job cooking the data.
I agree with the above, Pfizer did a better job marketing the data. With the recent data, not sure the traditional NSAIDs do not pose a cardiovascular risk.
2 comments:
Funny part is... Celepfizer is no safer. Pfizer just did a better job cooking the data.
I agree with the above, Pfizer did a better job marketing the data. With the recent data, not sure the traditional NSAIDs do not pose a cardiovascular risk.
Post a Comment